WM Technology (MAPS) Company Overview

TORONTO, Jan. 20, 2025 (GLOBE NEWSWIRE) -- PharmAla Biotech Holdings Inc. (“PharmAla” or the “Company”) (CSE: MDMA) (OTC:MDXXF), a biotechnology company focused on the research, development, and manufacturing of LaNeo™ MDMA and novel derivatives of MDMA (MDXX class molecules), is pleased to announce that it has executed an agreement with Merhavim Mental Health Centre of Beer Yaakov, Israel (“Merhavim”). All data generated in the clinical trial, entitled “MDMA Assisted Psychotherapy for PTSD of Early Sexual Trauma Compared to All Trauma in Adulthood”, will be licensed to PharmAla for regulatory and commercial purposes in exchange for the clinical trial material, which will be provided by PharmAla on a zero-cost basis.

PHILADELPHIA, PA / ACCESSWIRE / December 20, 2024 / Kaskela Law LLC announces that it has commenced an investigation into WM Technology, Inc. (NASDAQ:MAPS) on behalf of the company's current shareholders. Additional information: https://kaskelalaw.com/case/wm-technology/ On December 18, 2024, WM Technology announced that it had received a proposal from certain company founders to purchase all of the outstanding shares of the company's common stock at a price of $1.70 per share.

NEW YORK, NY / ACCESSWIRE / December 17, 2024 / Pomerantz LLP announces that a class action lawsuit has been filed against WM Technology, Inc. ("WM" or the "Company") (NASDAQ:MAPS). Such investors are advised to contact Danielle Peyton at [email protected] or 646-581-9980, (or 888.4-POMLAW), toll-free, Ext.

NEW YORK, NY / ACCESSWIRE / December 16, 2024 / If you suffered a loss on your WM Technology, Inc. (NASDAQ:MAPS) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/wm-technology-inc-lawsuit-submission-form?prid=116890&wire=1 or contact Joseph E. Levi, Esq.

NEW YORK, Dec. 16, 2024 (GLOBE NEWSWIRE) -- Levi & Korsinsky, LLP notifies investors in WM Technology, Inc. ("WM Technology, Inc." or the "Company") (NASDAQ: MAPS) of a class action securities lawsuit.

NEW YORK, NY / ACCESSWIRE / December 16, 2024 / If you suffered a loss on your WM Technology, Inc. (NASDAQ:MAPS) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/wm-technology-inc-lawsuit-submission-form?prid=116834&wire=1 or contact Joseph E. Levi, Esq.

LOS ANGELES, CA / ACCESSWIRE / December 16, 2024 / The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against WM Technology, Inc. ("WM Technology" or "the Company") (NASDAQ:MAPS) for violations of 10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission.\ Investors who purchased the Company's securities between May 25, 2021, and September 24, 2024, inclusive (the "Class Period"), are encouraged to contact the firm before December 16, 2024.

NEW YORK, NY / ACCESSWIRE / December 16, 2024 / If you suffered a loss on your WM Technology, Inc. (NASDAQ:MAPS) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/wm-technology-inc-lawsuit-submission-form?prid=116765&wire=1 or contact Joseph E. Levi, Esq.

NEW YORK , Dec. 16, 2024 /PRNewswire/ -- The Gross Law Firm issues the following notice to shareholders of WM Technology, Inc. (NASDAQ: MAPS). Shareholders who purchased shares of MAPS during the class period listed are encouraged to contact the firm regarding possible lead plaintiff appointment.